SPRO earnings
Spero Therapeutics (SPRO) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- SPRO beat EPS estimates in 8 of its last 10 reports.
SPRO earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 12, 2026 | -0.76 | -0.47 | -61.70% | $0.00 |
| Q2 2026 | Aug 12, 2026 | -0.16 | -0.17 | 5.88% | $0.00 |
| Q1 2026 | May 13, 2026 | -0.13 | -0.18 | 27.78% | $258.00K |
| Q4 2025 | Mar 26, 2026 | 0.53 | -0.20 | 365.00% | $41.30M |
| Q3 2025 | Nov 13, 2025 | -0.13 | – | – | $5.44M |
| Q2 2025 | Aug 12, 2025 | -0.03 | -0.38 | 92.11% | $14.19M |
| Q1 2025 | May 13, 2025 | -0.25 | -0.55 | 54.55% | $5.87M |
| Q4 2024 | Mar 27, 2025 | -0.38 | -0.35 | -8.57% | $15.04M |
| Q3 2024 | Nov 14, 2024 | -0.32 | – | – | $13.47M |
| Q2 2024 | Aug 5, 2024 | -0.33 | -0.35 | 5.71% | $10.20M |
| Q1 2024 | May 15, 2024 | -0.24 | – | – | $9.27M |
| Q4 2023 | Mar 13, 2024 | 0.96 | – | – | $73.52M |
| Q3 2023 | Nov 13, 2023 | 0.02 | -0.15 | 113.33% | $25.47M |
| Q2 2023 | Aug 10, 2023 | -0.23 | – | – | $2.72M |
| Q1 2023 | May 11, 2023 | -0.25 | -0.35 | 28.57% | $2.07M |
| Q4 2022 | Mar 30, 2023 | 0.55 | – | – | $47.44M |
| Q3 2022 | Nov 14, 2022 | -0.33 | – | – | $2.01M |